Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Explore key tips on what not to do when planning for retirement. Avoid common missteps to ensure a successful retirement.
26,407 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
Meta Platforms sits at a critical crossroads: its massive user network is powerful, but an ambitious AI data-center s...
Tilray Brands is set to report on July 28. This article breaks down whether should tilray brands stock be on your rad...
Looking at AbbVie today, investors often ask what makes reasons abbvie stock like this compelling. This article break...
DES delivers monthly payouts tied to a cash-dividend weighted small-cap index. The income looks reliable, but a conce...
Ethereum traded near a three-month low as risk-off conditions weighed on prices. Analysts flagged ethereum (eth) indi...
The SEC moves to pilot on-chain equity trading as the Clarity Act advances to the Senate floor. Regulators emphasize ...
Investors are debating the right holding period for XRP to maximize returns. New market patterns show patience throug...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
A federal judge granted final approval to a $110 million shareholder settlement linked to Wells Fargo mortgage oversi...
The nuclear energy sector is staging a comeback. This article breaks down two top stock ideas, explains why they matt...